Crinetics Pharmaceuticals, Inc. (CRNX) Financials

CRNX Assets vs Liabilities

DateAssetsLiabilities
2024-03-31 978.2 million 103.2 million
2023-12-31 635.4 million 96.2 million
2023-09-30 641.5 million 93.8 million
2023-06-30 293.3 million 39.1 million

CRNX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-03-31 -54.2 million 13.5 million
2023-12-31 -39.5 million 11.6 million
2023-09-30 -44.8 million 11.0 million
2023-06-30 -46.0 million 10.2 million

CRNX Net Income

No data available :(

CRNX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-03-31 901.0 million - 52.5 million
2023-12-31 558.6 million - 51.7 million
2023-09-30 554.7 million - 52.2 million
2023-06-30 264.5 million - 2.6 million

CRNX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-03-31 72.3 million
2023-12-31 67.1 million
2023-09-30 56.8 million
2023-06-30 54.3 million

CRNX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-03-31 1.3 million 52.9 million 20.8 million -
2023-12-31 935000 45.3 million 17.1 million -
2023-09-30 3.5 million 43.8 million 15.5 million -
2023-06-30 237000 40.6 million 13.3 million -

CRNX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-03-31 640000 474000
2023-12-31 - 262000
2023-09-30 346000 273000
2023-06-30 988000 398000

CRNX

Price: $51.40

52 week price:
15.76
51.91

Earnings Per Share: -3.69 USD

P/E Ratio: -10.14

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 265100

Market Capitalization: 4.0 billion

Links: